{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:59:46Z","timestamp":1790434786020,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Trans\u2010scleral diode laser cycloablation (cyclodiode) is effective in the short\u2010term management of refractory glaucoma where alternative treatments are not feasible. Long\u2010term outcomes of 5\u2010years or more are not well\u2010documented, particularly in relation to intraocular pressure (IOP) control, need for further procedures and complications such as hypotony and phthisis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A review was undertaken of patient medical records with refractory glaucoma who underwent cyclodiode at City Eye Centre in Brisbane from 2012 to 2016. Data included sex, age, laterality, type of glaucoma, cyclodiode parameters, number of glaucoma medications, visual acuity and treatment with acetazolamide. Data were analysed using generalised linear modelling and Kaplan\u2013Meier analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 54 eyes in 54 patients (29 M:25F) with a mean age of 66\u2009years (range 15\u201385\u2009years) with a minimum of 5\u2009years follow up were included. The mean number of burns was 23.3 (range 12\u201340) over 180\u2013270 degrees, mean power per burn was 1967\u2009mW (range 1500\u20132000\u2009mW), with a mean duration of 1981\u2009ms (1500\u20132000\u2009ms). The mean pre\u2010treatment IOP was 31.5\u2009mmHg (range 17\u201356\u2009mmHg) and mean IOP 5\u2009years post\u2010treatment was 16.1\u2009mmHg (2\u201342\u2009mmHg). The mean number of pre\u2010treatment medications was 3.6 (range 1\u20136) and 2.7 (range 0\u20135) 5\u2009years post treatment, including 5 (8.3%) on oral acetazolamide. Complications of cyclodiode were seen in 6 (11.1%) patients, including 3 (5.0%) cases of hypotony, and 2 (3.3%) phthisis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Cyclodiode is often utilised for end\u2010stage glaucoma when the IOP is uncontrolled on medical treatment and drainage surgery is not indicated, resulting in long\u2010term reduction of IOP and the number of medications, including acetazolamide. Hypotony and phthisis can be significant complications.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ceo.14185","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T03:28:01Z","timestamp":1667014081000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long\u2010term limitations and complications of trans\u2010scleral diode laser cycloablation for refractory glaucoma"],"prefix":"10.1111","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-2733","authenticated-orcid":false,"given":"Tabitha M.","family":"Scott","sequence":"first","affiliation":[{"name":"City Eye Centre  Brisbane QLD Australia"},{"name":"Mayne Academy of Surgery University of Queensland  Herston QLD Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5504-3169","authenticated-orcid":false,"given":"Eugene R.","family":"Ting","sequence":"additional","affiliation":[{"name":"City Eye Centre  Brisbane QLD Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Vincent","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Science Queensland University of Technology  Kelvin Grove QLD Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-1473","authenticated-orcid":false,"given":"Graham A.","family":"Lee","sequence":"additional","affiliation":[{"name":"City Eye Centre  Brisbane QLD Australia"},{"name":"Mayne Academy of Surgery University of Queensland  Herston QLD Australia"},{"name":"Department of Ophthalmology The Mater Hospital  Brisbane QLD Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"5","article-title":"Evolution of cyclophotocoagulation","volume":"13","author":"Ndulue JK","year":"2018","journal-title":"J Ophthalmic Vis Res"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(61)91110-2"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0837-3"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01354.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30109-2"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.10.1252"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702345"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.18559"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-017-0782-1"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.116533"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-007-0708-0"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2000.00320.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002793"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001205"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.3.311"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2010.174"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12088"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.4.381"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.14185","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ceo.14185","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.14185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:27:36Z","timestamp":1692656856000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ceo.14185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1111\/ceo.14185"],"URL":"https:\/\/doi.org\/10.1111\/ceo.14185","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"2022-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}